SCHEMBL15075604

SCHEMBL15075604

c1ccc(-c2nc(-c3ccncc3)[nH]c2-c2cccs2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMPD3 Q9NY59 4/20 0.76
MAPT P10636 8/20 0.70
KDM4E B2RXH2 5/20 0.70
MAPK13 O15264 9/20 0.70
MAPK12 P53778 9/20 0.70
MAPK11 Q15759 9/20 0.70
MAPK14 Q16539 9/20 0.70
RAF1 P04049 5/20 0.70
MAPK9 P45984 1/20 0.70
ALDH1A1 P00352 4/20 0.69
HPGD P15428 4/20 0.69
MEN1 O00255 3/20 0.69
KMT2A Q03164 3/20 0.69
CYP1A2 P05177 2/20 0.69
CYP2C19 P33261 2/20 0.69
CYP3A4 P08684 1/20 0.69
CYP2C9 P11712 1/20 0.69
PPARG P37231 1/20 0.69
NCOA2 Q15596 1/20 0.69
NCOA1 Q15788 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15075609 0.88 SMPD3 (0.67) SMPD3MAPTKDM4EMAPK13MAPK12
SCHEMBL7228717 0.83 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL2949385 0.83 MAPK13 (1.00) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL14059826 0.82 KDM4E (1.00) SMPD3MAPTKDM4EMAPK13MAPK12
SCHEMBL244059 0.80 SMPD3 (0.80) SMPD3MAPTKDM4EALDH1A1HPGD
SCHEMBL8309758 0.80 MAPK13 (0.75) MAPTKDM4EMAPK13MAPK12MAPK11
SCHEMBL68380 0.80 MAPK13 (0.75) MAPK13MAPK12MAPK11MAPK14RAF1
SCHEMBL6448187 0.77 MAPT (0.90) MAPTKDM4EMAPK13MAPK12MAPK11
SCHEMBL22291134 0.76 SMPD3 (1.00) SMPD3MAPTKDM4EALDH1A1HPGD
SCHEMBL8309945 0.76 MAPK14 (0.73) MAPK13MAPK12MAPK11MAPK14RAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130165472-A1 HETEROARYLS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2013-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130165472-A1 HETEROARYLS AND USES THEREOF PIK3R4, VPS4B, PIK3C2A SMPD3 1402/4885MAPT 4467/4885KDM4E 1283/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.